FDA approval fast-track for animal feed additives that alter livestock biology

What it does

This bill creates a new regulatory category called 'zootechnical animal food substances'—additives given to farm animals to improve digestion, reduce foodborne pathogens, or alter gut bacteria—and requires them to be approved as food additives rather than drugs. The bill exempts these substances from drug approval pathways while still requiring FDA safety review and labeling that states they are not for treating disease. Producers of animal feed additives and the livestock industry benefit by gaining a faster, less stringent approval pathway than traditional drug regulation.

Why we flagged it

The bill's core function is to move a class of animal-health substances from drug regulation into food-additive regulation, creating a faster approval pathway. This is a deliberate regulatory downshift, not a safety measure or public-health initiative.

What the text implies

• Substances that alter animal gastrointestinal microbiome and reduce foodborne pathogens may have indirect effects on human health via the food chain, but the bill routes them through food-additive review (section 409) rather than drug review (section 512), which typically involves more extensive safety data and post-market surveillance.
• The bill allows the Secretary to exclude substances from the zootechnical category 'through notice and comment rulemaking,' creating a regulatory escape valve that could narrow the category over time or allow substances to slip between regulatory frameworks.
• Labeling requirement ('Not for use in diagnosis, cure, mitigation, treatment, or prevention of disease') is a bright-line rule, but producers could market the same substance as a 'structure/function' modifier, which is permitted under section 409(l)(2), potentially obscuring therapeutic intent.
• The bill does not establish post-market surveillance or adverse-event reporting requirements specific to zootechnical substances, unlike drug approval, which may leave safety gaps if unintended effects emerge after widespread use in livestock.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Citizens benefit from potentially lower food costs if approval acceleration reduces producer costs, and the bill does require FDA safety review and labeling. However, the bill creates a regulatory gap: substances that affect animal body structure and function are being routed through a less stringent approval process than drugs, potentially reducing the depth of safety scrutiny for substances that enter the food chain via treated animals.

Who stands to gain

• animal feed manufacturers and additives producers
• livestock producers (via lower compliance costs and faster market access)
• biotechnology and probiotics companies developing gut-health products for animals

Named in the bill

FDA (Food and Drug Administration), HHS (Department of Health and Human Services), Federal Food, Drug, and Cosmetic Act, Section 201 (definitions), Section 409 (food additives), Section 512 (animal drug approval), Section 571 (conditional animal drug approval), Section 572 (indexed animal drugs)

Where it stands

9 cosponsors: 4 Democrats, 4 Republicans, 1 Independents.

• May 22, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• May 22, 2025 — Referred to Senate Committee on Agriculture, Nutrition, and Forestry · Congress.gov: “Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

7 lobbying clients named this bill on 10 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $1,448,009 in lobbying spend. A filing names 16 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 86% of bills with at least one filing.

Roger Marshall, the sponsor, reported $1,837,391 in PAC receipts in the 2026 cycle.

• International Dairy Foods Association — $540,000 on 2 filings
• National Milk Producers Federation — $518,009 on 2 filings
• Elanco Animal Health Incorporated — $230,000 on 1 filing
• International Dairy Foods Association — $90,000 on 2 filings
• Edge Dairy Farmer Cooperative — $30,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.